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Juvenile myoclonic epilepsy (JME) is an idiopathic, age-related generalized epileptic syndrome, featuring generalized
tonic–clonic and absence seizures as well as myoclonic jerks. Except for some case reports, little is known about type and
frequency of nonconvulsive status epilepticus (NCSE) in adult patients with JME. In a retrospective study we therefore reviewed
all patients with JME, who had been referred to our hospital between 1994 and 1999 for the occurrence of NCSE. Of the
69 patients with JME seen within these 6 years three women had typical absence status—one of them two times—and one
woman had impulsive-petit-mal status. All four patients had a history of myoclonic, absence and generalized tonic–clonic
seizures. Because of the extreme rarity of impulsive-petit-mal status the corresponding case history is presented in detail.
According to our findings the prevalence of NCSE in JME can be estimated at 5.8%, the incidence at 1.2% per year with a clear
preponderance of female gender.
c© 2002 BEA Trading Ltd. Published by Elsevier Science Ltd. All rights reserved.
Key words: juvenile myoclonus epilepsy; Janz syndrome; nonconvulsive status epilepticus; myoclonic status.
1. INTRODUCTION
Juvenile myoclonic epilepsy (JME) is an idiopathic,
age-related generalized epileptic syndrome, that fea-
tures generalized tonic–clonic as well as absence
seizures and myoclonic jerks. Seizures are normally
provoked by sleep deprivation, alcohol and flickering
light. The prevalence of this syndrome is higher
than usually appreciated and should account for
about 5–10% of all types of epilepsy1–3. The
characteristic EEG pattern consists of generalized,
symmetric spike- and polyspike-slow wave discharges
frequently accompanied by myoclonic jerks4, 5. The
usual treatment options are either valproic acid6 or
lamotrigine7.
Up to now little has been known about the type and
frequency of nonconvulsive status epilepticus (NCSE)
in patients with JME, this topic has been addressed
in only few case reports. In a retrospective study
we therefore systematically reviewed all patients with
JME, who were referred to our hospital between 1994
and 1999, for the occurrence of NCSE.
2. PATIENTS AND METHODS
The Department of Neurology of the University
Clinic Mu¨nster provides a neurological service to
500 000 inhabitants aged >16 years in the area around
Mu¨nster. JME was diagnosed, when patients had
myoclonic jerks (MJ), especially upon awakening
and generalized polyspike-waves (PSW) in EEG.
Additionally absence seizures (AS) and generalized
tonic–clonic seizures could be present but were not
mandatory for diagnosis. All patients with JME, who
were treated between 1994 and 1999 in our epilepsy
devision, were included in this study. All patients
had been investigated by thorough history taking
and by neurological examination. EEG recordings
were performed on a 24-channel EEG machine with
21 electrodes placed according to the 10–20 system.
Diagnosis was made in accordance with the proposal
of the International League Against Epilepsy8, 9.
In brief, NCSE was defined as state of impaired
consciousness without convulsions lasting at least
60 minutes. In more detail, the different status forms
1059–1311/02/$22.00/0 c© 2002 BEA Trading Ltd. Published by Elsevier Science Ltd. All rights reserved.
336 R. Dziewas et al.
observed in this study were defined as follows: Typical
absence status (TAS) appears clinically either as
stupor or as a fluctuating confusional state. Mild infre-
quent myoclonic jerks or automatisms can be present,
the ictal EEG features generalized continous or
discontinous spike-wave discharge10. It is worth men-
tioning that complex partial seizures can sometimes
be hardly distinguishable from TAS. Ictal EEG shows
continuous or intermittent focal or generalized spikes
or sharp and slow waves. Myoclonic status (MS) is
characterized by uncoordinated jactations of variable
frequency and intensity with slight impairment of
consciousness. The characteristic ictal EEG pattern
shows intermittent spike-wave and polyspike-wave
discharges11.
3. RESULTS
Between 1994 and 1999 69 patients (46 women, mean
age 29.4 ± 10.2 and 23 men, mean age 30.9 ± 11.3)
with JME were examined and treated at our hospital.
Age at disease-onset was 16.6 ± 5.4 years for the
whole cohort without significant difference between
the sexes (women 16.4± 6.0, men 16.9± 4.0).
Seizure types were myoclonic in 100%, absences in
43% and generalized tonic–clonic in 90% (Fig. 1).
Actual treatment consisted of valproic acid (VPA)
monotherapy in 27 (39.0%), lamotrigine (LTG)
monotherapy in 15 (21.7%), ethosuximide monother-
apy in three (4.3%), carbamazepine (CBZ) monother-
apy in three (4.3%), a combination therapy of VPA
and LTG in seven (10.1%), of LTG and CBZ in
6 (8.7%) and of VPA and CBZ in three (4.3%)
patients. Five (7.2%) patients refused medication.
Remarkably 24 (34.8%) patients had been treated
with carbamazepine or phenytoin and two (2.8%) with
phenobarbital for some time.
In three female patients (4.3%) aged 28, 34, and
51 TAS was diagnosed and treated successfully with
clonazepam, one of them twice during the study
period. In all these patients a typical history of
myoclonic jerks and absence seizures as well as
generalized tonic–clonic seizures was revealed later.
Two patients had experienced TAS before. At the time
of TAS, treatment comprised of CBZ monotherapy
in three instances. In one instance therapy with an
unknown anticonvulsant had just been discontinued by
the patient herself.
One female patient, aged 69, presented with
myoclonic status (MS). She also had a history of
myoclonic jerks, absence seizures and generalized
tonic–clonic seizures. No other status forms were
observed and no male JME patient was affected.
Therefore the prevalence of nonconvulsive status
epilepticus in this study amounts to 5.7%, the corre-
sponding incidence totals 1.2% per year. For the TAS-
subgroup the prevalence was 4.3% (incidence 0.87%
per year) and for MS-subgroup 1.4% (incidence
0.28% per year) respectively. Since NCSE occured
only in patients with myoclonic jerks, absence seizures
and generalized tonic–clonic seizures the prevalence
for this subgroup was figured at 10.8% and the
corresponding incidence at 2.2% per year.
Fig. 1: Clinical characteristics of patients with juvenile
myoclonic epilepsy (JME). MJ = myoclonic jerks,
AS = Absence seizures, GTCS = generalized tonic–clonic
seizures.
Case report
Because of the extreme rarity of MS we wish to
present the last case in greater detail. This 69 year
old retired lawyer had a history of epilepsy since
she had been a teenager. In the last two years
she was treated in our hospital several times after
having suffered generalized tonic–clonic seizures in
conjunction with alcohol intake. In her adolescence
she had experienced quite frequently myoclonic
jerks of arms and legs shortly after awakening and
periods of minutes during which she seemed to
be sleepy and lethargic. Since her mid-thirties she
had infrequently experienced GTCS. An ictal EEG
had never been registered. Recent interictal EEGs
had constantly been abnormal with mild general
slowing but no focus or sharp-slow wave discharges.
Analysis of cerebrospinal fluid was normal. MR-
images of the head showed a leukoencephalopathy,
leading to the diagnosis of symptomatic epilepsy
with secondary GTCS. For several decades she had
been treated with phenytoin, (PHT) without, however,
taking medication regularly as blood-level monitoring
revealed. Beside the epilepsy she had suffered from
arterial hypertension for many years.
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Table 1: Published patients with JME and NCSE.
Source Publishing year Number of patients Ictal EEg Type of NCSE Sex/age (yr)
Gru¨neberg 12 1969 1 yes MS 32/f
Christian 13 1980 1 yes MS 54/m
Christian 14 1982 1 yes MS 51/?
Asconape´a, 5 1984 5 no MS ?
Matthes 15 1992 1 yes MS 40/f
Salas Puigb, 16 1994 18 yes (one case) MS ?
Gentona, 17 2000 3 no MS ?
Sheth 18 2000 2 no MS 28/f, 15/f
Tomson 19 1992 1 no TAS ?
Kimura 20 1996 2 yes TAS 10/f; 12/f
Agathonikou 21 1998 2 no TAS 25/f; 69/m
Obeid 22 1999 2 yes TAS 22/m; 16/m
a The article does not state, if authors personally observed the MS or if this diagnosis was based on the patient’s report. b One MS was
documented by EEG. The other cases were based on the patients’ reports.
At the occasion we want to report on, the patient
was admitted to our hospital, because she had been
in a sleepy state for a few hours, being inconstantly
able to answer simple questions, e.g. giving her name.
Her thinking was severely slowed and her memory
was disturbed. A few times a minute she performed
symmetrical jerks with her arms and backward
twitches with her trunk and head. Neurological
examination revealed no other pathological finding.
An EEG showed generalized polyspike and slow wave
discharges and myocloclonic jerks (Fig. 2).
We therefore diagnosed MS and, despite the
pathological MRI, we finally proposed JME as the
underlying condition. After fractionated administra-
tion of 2 mg clonazepam the myoclonic jerks stopped
and the patient’s vigilance and EEG immediately
returned to her praemorbid state. She had amnesia
for the time of the status. As at earlier occasions she
remained uncooperative. Again she refused to change
her antiepileptic medication and left our clinic the
next morning.
4. DISCUSSION
This retrospective study attempts to close a gap in the
existing literature on JME. Whereas much is known
about its incidence, its clinical and EEG features
and, last, but not least, about therapy options, the
question of types and frequencies of NCSE in JME
had not often been investigated before systematically.
This topic has largely been addressed in case reports.
Some JME patients, who suffered NCSE, can be
found in clinical series, which were collected with
different aims.
Other authors report on NCSE without giving
the exact diagnosis of the underlying epileptic
syndrome23, 24.
In this retrospective study three women out of
69 patients with JME suffered TAS, one of them
twice, whereas only one woman experienced MS.
Other status types were not observed. The prevalence
of NCSE in patients with JME therefore reaches 5.8%,
the incidence 1.2% per year in this sample. The
prevalence of TAS amounts to 4.3% (incidence 0.96%
per year). This corresponds well to the results of
Agathonikou et al.21 (Table 1), who diagnosed this
status type in two of 30 JME patients (6.7%), when
analysing the frequency of TAS in adults. This
was much lower than, in the same study, patients
with phantom absences and generalized tonic–clonic
seizures (46.2%), perioral myoclonia with absences
(57.1%) and eyelid myoclonia with absences (18.2%).
As in our study, the JME patients affected by TAS all
had a history of myoclonic jerks, absence seizures and
generalized tonic–clonic seizures. This gives reason to
speculate that this particular syndrome predisposes for
TAS in patients with JME.
The prevalence of MS in our study was 1.4%. This is
in accordance with Christian’s suggestion13, that MS
occurs only very rarely. Remarkably, in a series of 85
JME patients, 21% of them had MS16. However, in
17 patients this diagnosis was based on the patient’s
report alone, only one case (1.2%) was witnessed by
the authors and documented by EEG.
Tomson et al.19, in their retrospective study used
an opposite approach and analysed the frequency of
different epileptic syndromes in a large series of NCSE
in adults. Whereas five of 32 patients had a history of
absence epilepsy only one had JME, thus suggesting
again, that NCSE in patients with JME is a rare event.
Whereas complex partial status, which often resem-
bles TAS clinically, is usually difficult to treat, TAS
and MS seem to respond well to administration of
benzodiaszepines such as diazepam or preferentially
clonazepam19. Our study gave further evidence of this
338 R. Dziewas et al.
Fi
g.
2:
EE
G
o
ft
he
m
yo
cl
on
ic
st
at
us
in
a
69
ye
a
r
o
ld
fe
m
a
le
w
ith
juv
e
n
ile
m
yo
cl
on
ic
e
pi
le
ps
y.
(a)
Pe
rio
di
c
2.
5
H
z
sp
ike
a
n
d
po
lys
pi
ke
w
av
e
di
sc
ha
rg
es
w
ith
fro
nt
o-
ce
nt
ra
l
e
m
ph
as
is
co
n
tin
u
in
g
to
a
po
lys
pi
ke
a
n
d
sh
ar
p
w
av
e
bu
rs
tw
hi
ch
w
a
s
a
cc
o
m
pa
ni
ed
by
a
m
yo
cl
on
ic
jer
k;
(b)
EE
G
o
ft
he
sa
m
e
pa
tie
nt
a
fe
w
m
in
u
te
s
la
te
r
sh
ow
in
g
fo
u
r
o
f
th
es
e
se
iz
ur
es
in
o
n
e
m
in
u
te
.
Status epilepticus in JME 339
fact, as all four patients promptly recovered from the
status after administration of 1 to 2 mg clonazepam.
Apart from that, intravenous administration of VPA
may be another therapeutic option18.
All of our patients with NCSE were taking
inadequate medication at the time of presentation
(CBZ, PHT or none). This corresponds to the results
of Genton et al.17. They found worsening of epilepsy
in patients with JME, who were treated with CBZ
or PHT. Besides an increase of MJ two of their
patients suffered MS and one a mixed absence and
myoclonic status.
Despite its rare occurrence in patients with JME, MS
may be seen more often in patients with brain lesions
of different origin25. In this instance the treatment is
usually difficult and the prognosis is poor26.
Because of these fundamental differences between
symptomatic MS and MS in patients with idiopathic
generalised epilepsy we finally would like to propose
a modification of the international nomenclature.
The myoclonic seizures in JME were described by
Janz and Christian in 1957 as ‘impulsive petit mal’.
Therefore it would make sense to address myoclonic
status in these patients as ‘impulsive petit mal status’.
This term, rather than myoclonic status, was used
before the current classification was published in 1981
and could be restored in future classifications.
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